LRRC31 Antibody (FITC)

Background

LRRC31 is a protein implicated in cellular signaling and extracellular matrix remodeling expressed in various tissues including stromal and epithelial cells studies suggest it may function in regulating cellular adhesion migration and mechanotransduction processes particularly during tissue repair and fibrosis LRRC31 has also been linked to cancer biology where its upregulation has been observed in certain tumor types potentially influencing tumor progression and metastasis through its effects on stromal-epithelial interactions bioinformatics data associate LRRC31 with integrin-mediated signaling pathways and interactions with cytoskeletal proteins ongoing research focuses on its potential as a biomarker for tumor-associated stromal activity and its role in regulating extracellular matrix dynamics further studies are required to characterize its precise molecular functions and its potential applications in cancer and fibrotic disease therapies